{"first_name":"Mitchell","last_name":"deLong","permalink":"mitchell-delong","crunchbase_url":"http://www.crunchbase.com/person/mitchell-delong","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Fri Mar 04 11:42:00 UTC 2011","updated_at":"Fri Mar 04 11:43:48 UTC 2011","overview":"<p>Dr. Mitchell deLong joined Aerie as a Vice President in 2005. Prior to Aerie, Dr. deLong was a Research Scientist at Procter and Gamble. During his 13 years at P&amp;G, he invented the first class of reversible skin-lightening agents, including GirLiteâ„¢. Dr. deLong won two awards at P&amp;G for his work on prostaglandin and was among the first to recognize the hair-growth stimulating potential of the compounds since commercialized as Latisseâ„¢. Dr. deLong has been an Adjunct Professor of Chemistry at Duke University since 2006. Prior to that, he held the same position at the University of Cincinnati. He has filed over 43 patent applications, and holds 14 issued patents. Dr. deLong received his PhD in Synthetic Organic and Medicinal Chemistry with a concentration in Cancer Biology from the Department of Chemistry of Stanford University. </p>","image":null,"degrees":[],"relationships":[{"is_past":false,"title":"Vice-President, Chemistry R&D","firm":{"name":"Aerie Pharmaceuticals","permalink":"aerie-pharmaceuticals","type_of_entity":"company","image":{"available_sizes":[[[93,122],"assets/images/resized/0012/4935/124935v1-max-150x150.png"],[[93,122],"assets/images/resized/0012/4935/124935v1-max-250x250.png"],[[93,122],"assets/images/resized/0012/4935/124935v1-max-450x450.png"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}